Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphocyte Destruction”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableUnknownNCT01668381
What this trial is testing

Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 20
Not applicableStudy completedNCT03960021
What this trial is testing

Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin

Who this might be right for
Immune Evasion, TumorNeoplastic Cells, CirculatingCirculating Tumor Cell+2 more
Institut Bergonié 20
Not applicableUnknownNCT03193710
What this trial is testing

The Effects of General Anesthetics on Lymphocytes in Patients Undergoing Colorectal Cancer Resection and Mechanism Involved

Who this might be right for
Colorectal Cancer MetastaticSurvival RateGeneral Anesthetics Toxicity+2 more
Guizhi Du 260
Large-scale testing (Phase 3)Study completedNCT02851784
What this trial is testing

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Chinese PLA General Hospital 40
Not applicableUnknownNCT00190502
What this trial is testing

Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Institute for Clinical and Experimental Medicine 28
Testing effectiveness (Phase 2)Ended earlyNCT01495572
What this trial is testing

Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Temporarily pausedNCT02026362
What this trial is testing

Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).

Who this might be right for
Hepatocellular Carcinoma
HRYZ Biotech Co. 100